The US District Court for the District of Massachusetts ordered EOFlow (KOSDAQ:294090) to pay $452 million to Massachusetts-based medical device company Insulet Corporation in damages for misappropriating the latter's trade secrets.
The fine comprises $170 million in compensation and $282 million exemplary for willful misappropriation. The South Korean smart wearable drug delivery solution provider's ability to pay the amount remains unclear, according to a press release by Insulet on Wednesday.
Shares of EOFlow plunged nearly 30% at market close on Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments